BioSpace News Archive

At the American Society of Mass Spectrometry (ASMS) conference October 31 to November 4 in Philadelphia, 908 Devices Inc. (Nasdaq: MASS) is presenting several talks and posters on the use of high-pressure mass spectrometry and microfluidics separation technologies to accelerate drug discovery workflows, including in metabolomics and proteomics applications.

Axial today announced that the company received clearance from the U.S. Food and Drug Administration (FDA) of its investigational new drug (IND) application for lead candidate, AB-2004

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that it will release its third quarter 2021 financial results on Wednesday, November 3, 2021, before the markets open.

Bristol Myers Squibb Reports Third Quarter Financial Results for 2021

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“ Teva ”) announced today that it has commenced tender offers (the “ Offers ”) to purchase for cash for a combined aggregate purchase price

Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), today announced that it has successfully synthesized a novel psilocin analogue with improved pharmaceutical properties to further expand its library of patent-pending tryptamines.

InflaRx N.V. announces positive data from the third cohort of patients in the Phase IIa open-label study with vilobelimab in Pyoderma Gangraenosum (PG).

Otonomy, Inc. today announced multiple presentations at the upcoming Neuroscience 2021 meeting

KemPharm, Inc. today announced that research involving AZSTARYS ® is being featured in a poster presentation during the 2021 Psych Congress being held both virtually and in-person in San Antonio, Texas

Cardurion Pharmaceuticals Announces Investment of up to $300 Million From Bain Capital